Literature DB >> 17905010

EMR for early gastric cancer in Korea: a multicenter retrospective study.

Jae J Kim1, Jun Haeng Lee, Hwoon-Yong Jung, Gin Hyug Lee, Joo Yong Cho, Chang Beom Ryu, Hoon Jai Chun, Jong Jae Park, Wan Sik Lee, Hyun Soo Kim, Moon Gi Chung, Jeong Seop Moon, Seok Reyol Choi, Geun Am Song, Hyun Yong Jeong, Sam Ryong Jee, Sang Yong Seol, Yong Bum Yoon.   

Abstract

BACKGROUND: EMR has been accepted as a treatment modality for selected cases of early gastric cancer (EGC) in Japan. However, long-term outcomes after EMR for EGC have not been fully documented.
OBJECTIVES: We reviewed the experiences of EMR for EGC in Korea, with emphasis on the long-term outcome.
DESIGN: Multicenter, retrospective study.
METHODS: Data were collected retrospectively by use of the on-line database registry system. From January 2000 to December 2002, 514 EGCs in 506 patients were treated by EMR in 13 institutions in Korea. Median age of the patients was 60 years (range 45-83 years). The resection was regarded as incomplete if histopathologic examination revealed a positive resection margin or submucosal invasion or positive lymphovascular invasion or undifferentiated histologic diagnosis.
RESULTS: The most commonly used technique was circumferential precutting followed by snare resection (EMR-P, n = 269, 52.3%). Complete resection and incomplete resection after EMR were confirmed in 399 lesions (77.6%) and 103 lesions (20.0%), respectively. For completely resected mucosal cancers (n = 399), the median duration of follow-up was 23.5 months (range 5-70 months). In this group, local recurrence was detected in 24 cases (6.0%) with a median interval between EMR and recurrence of 17.9 months (range 3.5-51.7 months). There were 3 cases with perforation and 71 cases with bleeding. No deaths were related to recurrence of gastric cancer during the overall median follow-up period of 39 months. LIMITATIONS: Multicenter retrospective design, no controls.
CONCLUSIONS: EMR is an effective therapeutic modality for selected cases of EGC in Korea.

Entities:  

Mesh:

Year:  2007        PMID: 17905010     DOI: 10.1016/j.gie.2007.04.013

Source DB:  PubMed          Journal:  Gastrointest Endosc        ISSN: 0016-5107            Impact factor:   9.427


  44 in total

1.  Outcome after endoscopic submucosal dissection for early gastric cancer in Korea.

Authors:  Jun Haeng Lee; Su Jin Hong; Jae Young Jang; Seong Eun Kim; Sang Young Seol
Journal:  World J Gastroenterol       Date:  2011-08-21       Impact factor: 5.742

2.  Do you have what it takes for challenging endoscopic submucosal dissection cases?

Authors:  Kyoung-Oh Kim; Sung Jung Kim; Tae Hyeon Kim; Jong-Jae Park
Journal:  World J Gastroenterol       Date:  2011-08-21       Impact factor: 5.742

3.  Efficacy and safety of endoscopic submucosal dissection for early gastric cancer in patients with comorbid diseases.

Authors:  Beom Jin Kim; Tae Hoon Chang; Jae J Kim; Byung-Hoon Min; Jun Haeng Lee; Hee Jung Son; Poong-Lyul Rhee; Jong Chul Rhee; Kyung Mee Kim; Chul Keun Park
Journal:  Gut Liver       Date:  2010-06-16       Impact factor: 4.519

4.  Endoscopic treatments of gastric mucosal lesions are not riskier in patients with chronic renal failure or liver cirrhosis.

Authors:  Young Lan Kwon; Eun Soo Kim; Kyung In Lee; Yong Jin Kim; Chang Wook Park; Yun Jung Kim; Hye Jin Seo; Kwang Bum Cho; Kyung Sik Park; Byoung Kuk Jang; Woo Jin Chung; Jae Seok Hwang
Journal:  Surg Endosc       Date:  2010-12-07       Impact factor: 4.584

5.  Endoscopic treatment of large colorectal tumors: comparison of endoscopic mucosal resection, endoscopic mucosal resection-precutting, and endoscopic submucosal dissection.

Authors:  Eun-Jung Lee; Jae Bum Lee; Suk Hee Lee; Eui Gon Youk
Journal:  Surg Endosc       Date:  2012-01-26       Impact factor: 4.584

6.  Endoscopic ultrasound-guided deep and large biopsy for diagnosis of gastric infiltrating tumors with negative malignant endoscopy biopsies.

Authors:  Xin-Xin Zhou; Hang-Hai Pan; Ali Usman; Feng Ji; Xi Jin; Wei-Xiang Zhong; Hong-Tan Chen
Journal:  World J Gastroenterol       Date:  2015-03-28       Impact factor: 5.742

7.  Clinical outcomes for perforations during endoscopic submucosal dissection in patients with gastric lesions.

Authors:  Seong Woo Jeon; Min Kyu Jung; Sung Kook Kim; Kwang Bum Cho; Kyung Sik Park; Chang Keun Park; Joong Goo Kwon; Jin Tae Jung; Eun Young Kim; Tae Nyeun Kim; Byung Ik Jang; Chang Hun Yang
Journal:  Surg Endosc       Date:  2009-09-30       Impact factor: 4.584

8.  Do we have enough evidence for expanding the indications of ESD for EGC?

Authors:  Hang Lak Lee; Chang Hwan Choi; Dae Young Cheung
Journal:  World J Gastroenterol       Date:  2011-06-07       Impact factor: 5.742

9.  Current status of endoscopic submucosal dissection for the management of early gastric cancer: a Korean perspective.

Authors:  Hoon Jai Chun; Bora Keum; Ji Hyun Kim; Sang Young Seol
Journal:  World J Gastroenterol       Date:  2011-06-07       Impact factor: 5.742

Review 10.  Future perspective of gastric cancer endotherapy.

Authors:  Takuji Gotoda; Chika Kusano; Fuminori Moriyasu
Journal:  Ann Transl Med       Date:  2014-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.